Accessibility Menu
QuidelOrtho logo

QuidelOrtho

(NASDAQ) QDEL

Current Price$17.39
Market Cap$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1983)+2%
5 Year-86%
1 Year-35%
1 Month+32%
QuidelOrtho last closing stock price
MetricPriceDate
Last closeUSD 17.382026-07-17
QuidelOrtho stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.87%USD 18.272026-07-10
1 month+32.37%USD 13.132026-06-17
3 month+36.74%USD 12.712026-04-17
Year to date-39.15%USD 28.562025-12-31
1 year-34.86%USD 26.682025-07-17
3 year-79.21%USD 83.582023-07-18
5 year-86.11%USD 125.122021-07-16
Since inception+2.24%USD 17.001983-10-18

QuidelOrtho Financials at a Glance

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.66B

Net Income (TTM)

-$1.21B

EPS (TTM)

-$17.82

P/E Ratio

-0.98

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$17.39

Volume

1,106,190.519

Open

$17.77

Previous Close

$17.38

Daily Range

$17.26 - $18.19

52-Week Range

$9.92 - $35.58

Estimated Earnings Date

Jul 29, 2026

QDEL News

BuyAlert-Purple.png

Rice Hall James Buys QuidelOrtho Stock

John BallardMar 9, 2026
BuyAlert-Green.png

QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires

Adé HennisMar 1, 2026
BuyAlert-Green.png

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs

Jonathan PoncianoDec 7, 2025
Foolcom-Featured.png

QuidelOrtho (QDEL) Fiscal Q2 EPS Beats

Motley Fool Markets TeamAug 6, 2025
Healthcare professional inspecting charts

Why QuidelOrtho Stock Bounced More Than 4% Higher Today

Eric VolkmanFeb 13, 2025
GettyImages-928320744-600x372-132bd13.jpg

QuidelOrtho Surpasses Expectations in Q3

Motley Fool Markets TeamNov 7, 2024
Stethescope atop US currency and coins

Why QuidelOrtho Stock Blasted 10% Higher Today

Eric VolkmanSep 5, 2024
Young man worried, laptop

Why QuidelOrtho Stock Is Crashing Today

Keith SpeightsFeb 14, 2024
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About QuidelOrtho

QuidelOrtho makes medical tests that help doctors find health problems quickly. These tools check for things like the flu and heart issues in hospitals. The company provides these diagnostic solutions to people across the globe.

The Testing Toolbox

  • Labs: Clinical chemistry and immunoassay tests that measure chemicals and proteins in bodily fluids for health evaluations.
  • Transfusion Medicine: Systems used for blood typing to ensure donor compatibility and screening for infectious diseases.
  • Point-of-Care: Rapid testing platforms like SOFIA and QUICKVUE that provide immediate results in clinics or at home.
  • Molecular Diagnostics: Genetic testing systems such as LYRA and SOLANA used to detect and identify infectious diseases.

Strategic Moves and Shifts

  • Initiated a plan in February 2024 to wind down the U.S. donor screening portfolio to exit lower-margin products.
  • Discontinued development of the SAVANNA molecular platform during the second quarter of 2025.
  • Announced a proposed acquisition of LEX Diagnostics to expand the company's technology and testing capabilities.
  • Recorded a $65 million charge in 2025 to begin discussions for terminating the joint business with Grifols.

What Makes QuidelOrtho Different?

The company maintains a global reach with manufacturing facilities in the U.S., U.K., and China to serve 140 countries. It utilizes a specialized sales force to support diverse settings from small urgent care clinics to large hospital laboratories.

The Fiscal Scorecard

  • Total revenue reached $723.6 million in Q4 2025, representing a 2.2% increase from the same period in 2024.
  • Operating losses narrowed to $66.3 million in Q4 2025, an improvement of 34% from the prior year.
  • Net loss improved by 26.7% year-over-year to $130.7 million for the fiscal year ended December 28, 2025.
  • Free cash flow rose to $86.6 million in Q4 2025, up 424.8% from $16.5 million in Q4 2024.
  • One individual customer accounted for 11% of the company's total revenues during the 2025 fiscal year.

Steady Evolution

QuidelOrtho is refocusing its operations by exiting lower-growth segments and investing in automated diagnostic software. This transition aims to align its global infrastructure with more profitable clinical and laboratory markets.

AI Generated • May 3, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

6,500

CEO

Brian J. Blaser, MBA

Website

www.quidelortho.com

Headquarters

San Diego, CA 92121, US

QDEL Financials

Key Financial Metrics (TTM)

Gross Margin

44.96%

Operating Margin

-36.85%

Net Income Margin

-45.57%

Return on Equity

-56.31%

Return on Capital

-19.33%

Return on Assets

-21.51%

Earnings Yield

-1.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

68.19M

Volume

1.11M

Avg. Volume

1.97M

Financials (TTM)

Gross Profit

$1.19B

Operating Income

-$979.20M

EBITDA

-$548.80M

Operating Cash Flow

$6.60M

Capital Expenditure

-$81.80M

Free Cash Flow

-$75.20M

Cash & ST Invst.

$140.40M

Total Debt

$2.87B

QuidelOrtho Performance Analysis

QuidelOrtho annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 3,263,100,00092.1%
20232023-12-31USD 2,993,500,000-8.3%
20242024-12-31USD 2,785,400,000-7.0%
20252025-12-31USD 2,727,000,000-2.1%
QuidelOrtho sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-29-11.4%
Q32025-09-2814.0%
Q42025-12-283.4%
Q12026-03-29-14.3%
QuidelOrtho annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 9.56-41.8%
20232023-12-31USD -0.15N/A
20242024-12-31USD -30.5420095.6%
20252025-12-31USD -16.69-45.3%
QuidelOrtho sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-29-1884.2%
Q32025-09-28-185.9%
Q42025-12-2881.9%
Q12026-03-2930.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$619.80M

-10.5%

Gross Profit

$263.80M

-23.2%

Gross Margin

42.56%

N/A

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$182.33K

N/A

Employees

6,500

N/A

Net Income

-$91.80M

-622.8%

EBITDA

$81.40M

-42.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$140.40M

+10.5%

Total Debt

$2.87B

+6.7%

Accounts Receivable

$486.70M

+11.4%

Inventory

$611.50M

+8.6%

Long Term Debt

$2.62B

+15.2%

Short Term Debt

$259.50M

-38.9%

Return on Assets

-21.51%

N/A

Return on Invested Capital

-20.98%

N/A

Free Cash Flow

-$26.80M

-135.4%

Operating Cash Flow

-$33.00M

-150.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AZTAAzenta, Inc.
$26.29-1.83%
VRDNViridian Therapeutics, Inc.
$18.03+0.00%
ATRCAtriCure, Inc.
$34.95-1.88%
LMATLeMaitre Vascular, Inc.
$101.63-1.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
TAT&T
$21.81-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$67.53-0.05%
SKHYSK Hynix
$154.03+0.01%

Questions About QDEL

What is the current price of QuidelOrtho?

QuidelOrtho is trading at $17.38 per share.

What is the 52-week range for QuidelOrtho?

Over the past 52 weeks, QuidelOrtho has traded between $9.92 and $35.58.

How much debt does QuidelOrtho have?

As of the most recent reporting period, QuidelOrtho reported total debt of $2.87B.

How much cash does QuidelOrtho have on hand?

QuidelOrtho reported $140.40M in cash and cash equivalents in its most recent financial results.

What is QuidelOrtho’s dividend yield?

QuidelOrtho does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services